SCHEMBL1819920

SCHEMBL1819920

COc1cc(-c2ccc3c(c2)N(S(=O)(=O)c2ccc(S)cc2)CCO3)ccc1C#N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.47
▸ CYP2C9 P11712 1/20 0.46
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ KMT2A Q03164 4/20 0.42
▸ MEN1 O00255 3/20 0.42
▸ MAPT P10636 2/20 0.42
▸ TP53 P04637 1/20 0.42
▸ POLB P06746 1/20 0.41
▸ SCN9A Q15858 2/20 0.38
▸ PKM P14618 4/20 0.37
▸ CPT1A P50416 3/20 0.37
▸ USP2 O75604 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ CPT1B Q92523 2/20 0.37
▸ CPT2 P23786 1/20 0.37
▸ PKLR P30613 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ PDE3B Q13370 2/20 0.36
▸ PDE3A Q14432 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1818577 0.91 NPC1 (0.58) NPC1CYP2C9CYP3A4CYP2D6KMT2A
SCHEMBL1818007 0.91 CYP2C9 (0.56) NPC1CYP2C9CYP3A4CYP2D6KMT2A
SCHEMBL1818967 0.91 CYP2C9 (0.48) NPC1CYP2C9CYP3A4CYP2D6KMT2A
SCHEMBL1816318 0.91 NPC1 (0.47) NPC1CYP2C9CYP3A4CYP2D6KMT2A
SCHEMBL1818733 0.89 CYP2C9 (0.47) NPC1CYP2C9CYP3A4CYP2D6KMT2A
SCHEMBL1819412 0.89 NPC1 (0.45) NPC1CYP2C9CYP3A4CYP2D6KMT2A
SCHEMBL1820258 0.88 NPC1 (0.45) NPC1CYP2C9CYP3A4CYP2D6KMT2A
SCHEMBL1817694 0.87 POLB (0.46) NPC1CYP2C9CYP3A4CYP2D6KMT2A
SCHEMBL1819918 0.87 NPC1 (0.48) NPC1CYP2C9CYP3A4CYP2D6KMT2A
SCHEMBL1816628 0.85 POLB (0.45) NPC1CYP2C9CYP3A4CYP2D6KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO claimed
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO disclosed
Send feedback